Navigation Links
Phase III Trial of Novartis Drug Afinitor® Met Primary Endpoint of Reducing SEGA Tumor Size in Patients With Tuberous Sclerosis
Date:7/7/2011

rs referred to in Novartis AG's current Form 20-F on file with the US Securities and Exchange Commission. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, believed, estimated or expected. Novartis is providing the information in this press release as of this date and does not undertake any obligation to update any forward-looking statements contained in this press release as a result of new information, future events or otherwise.

About NovartisLocated in East Hanover, New Jersey, Novartis Pharmaceuticals Corporation is an affiliate of Novartis AG, which provides healthcare solutions that address the evolving needs of patients and societies. Focused solely on healthcare, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care, cost-saving generic pharmaceuticals, consumer health products, preventive vaccines and diagnostic tools. Novartis is the only company with leading positions in these areas. In 2010, the Group's continuing operations achieved net sales of USD 50.6 billion, while approximately USD 9.1 billion (USD 8.1 billion excluding impairment and amortization charges) was invested in R&D throughout the Group. Headquartered in Basel, Switzerland, Novartis Group companies employ approximately 119,000 full-time-equivalent associates and operate in more than 140 countries around the world. For more information, please visit http://www.us.novartis.com.

Novartis is on Twitter. Sign up to follow @Novartis at http://twitter.com/novartis.

*Known as Votubia® (everolimus) tablets for this patient population in Switzerland. If approved in the EU for this patient population, the trade name will be Votubia.

# Rapamune® (sirolimus) and Torisel® (temsirolimus) are registered trad
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine technology :

1. Ampio Pharmaceuticals Announces Treatment of First Patient in Phase 1b Ampion-In -Knee (AIK) Trial for Osteoarthritis in Australia
2. GlaxoSmithKline Implements Next Phase of New Incentive Compensation Program for U.S. Sales Representatives
3. Ataluren Phase 2 Data in Nonsense Mutation Cystic Fibrosis Published in the European Respiratory Journal
4. Endo Announces Topline Results From Phase 2 Study of Axomadol in Chronic Low Back Pain
5. Phase III Study Shows Once-Daily NVA237 is Superior to Placebo and Similar to Tiotropium in Improving Lung Function in COPD
6. DNA Medicine Institute Awarded Two Phase III SBIR NASA Contracts for Its rHEALTH Sensor
7. Phase I of the Swedish/Issaquah Medical Center Campus to Open in July
8. The Lancet Publishes Data from Protege, MacroGenics Phase 3 Clinical Study of Teplizumab in Type 1 Diabetes Patients
9. Morphotek®, Inc. Announces Initiation of Farletuzumab Phase II Study in First-Line Treatment of Non-Small Cell Lung Cancer
10. Palatin Technologies, Inc. Initiates Enrollment in Phase 2b Trial With Bremelanotide in Women With Female Sexual Dysfunction
11. Cardium Announces Plans to Acquire Transdel Pharmaceuticals Phase 3 Topical Analgesic and Cosmeceutical Business Assets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... LONDON , December 24, 2014 /PRNewswire/ ... expected to grow at an average rate of 8.1%. ... and volume. Hip, knee and spine surgeries are the ... emerging economies they have a lower penetration. Increased number ... use of composites. Non-metallic orthopedic devices have gained popularity ...
(Date:12/24/2014)... ResMed (NYSE: RMD ) today announced its victory ... manufacturer BMC Medical Co., Ltd. The International ... infringe ResMed,s patents, and entered an order prohibiting BMC from ... United States : , iVolve nasal mask ... pillows mask , iVolve full face mask ...
(Date:12/24/2014)... 2014  Lockton Dunning Benefits, the ... the addition of Vice President Kim Foerster ... Pharmacy Consulting team, Excelsior Solutions. ... to the position.  Most recently, she worked as ... Specialty Pharmacy, where she has held various managerial ...
Breaking Medicine Technology:Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 2Use of Composites in Orthopedic Industry to Reach $596 Million by 2020 3ResMed Wins Patent Infringement Lawsuit Against Chinese Manufacturer BMC Medical 2Kim Foerster Joins Lockton Companies 2
... Jan. 4, 2012 "My philosophy in treating patients is ... fully achieve their goals," mentions Robert Paresi, MD, board ... Medical Center in Lake Geneva, Wisconsin and Mercy Regional ... recently joined Mercy Health System with the intent to provide ...
...   Kedem Pharmaceuticals Inc. (OTCBB: KDMP), a specialty ... pleased to announce that it has signed a contract ... Corealis Pharma, Inc. for the production of the phase ... therapeutic drug. The KDM-1102 drug is a new sublingual ...
Cached Medicine Technology:Fulfill New Year Resolutions with Cosmetic Surgery 2Kedem Pharmaceuticals Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials 2Kedem Pharmaceuticals Engages a FDA Compliant Contract Formulation Development Company for the Production of KDM-1102 Clinical Materials 3
(Date:12/25/2014)... FL (PRWEB) December 25, 2014 When head ... find themselves in a frenzy to get rid of it ... But families in Coral Gables now have the solution right ... second salon clinic location, Lice Troopers provides full spectrum head ... the Coral Gable area, including Sunset, Key Biscayne, Brickell, Coconut ...
(Date:12/25/2014)... 25, 2014 (HealthDay News) -- The risk of burns ... so you need to be extra cautious, an expert ... see a significant increase in patients coming in with ... Suffolk County Volunteer Firefighters Burn Center of Stony Brook ... be full of joy, but if not careful, could ...
(Date:12/25/2014)... Dennis Thompson HealthDay Reporter ... be closing in on a "fountain of youth" drug that ... of older adults, a new study suggests. Seniors received ... drug that targets a genetic signaling pathway linked to aging ... The experimental medication, a version of the ...
(Date:12/25/2014)... “ SmileStix ” was featured on NewsWatch as part of ... applications on the iOS, Android, and Windows markets. Andrew Tropeano, ... app review and shared with viewers how this is an ... saying goes, “A picture says a thousand words.” It’s true. ... single image, because each picture holds a unique and special ...
(Date:12/25/2014)... Rosa, CA (PRWEB) December 25, 2014 ... department visits and 2 million hospital admissions across the ... and Prevention ). The CDC’s National Hospital Ambulatory ... departments through a survey conducted in 2010. They estimated ... department visits that resulted in a primary diagnosis of ...
Breaking Medicine News(10 mins):Health News:Coral Gables Florida Gets Ready to Be Lice-Free with Lice Troopers 2Health News:Don't Let Burns Mar Your Holidays 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:An Application to Create Custom Stickers was Featured on NewsWatch Television on December 19, 2014 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 2Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 3Health News:Every Year Four Million Emergency Department Visits Result from Accidents Involving Bone Trauma 4
... Genaera,Corporation (Nasdaq: GENR ) today announced that ... of the Company,s common stock,has closed below the minimum ... the last 30 consecutive trading days., NASDAQ also ... it has,suspended for a three-month period the enforcement of ...
... Michael Chiarello and The American Association of,Orthodontists team up to provide ... ... recipes, ST. LOUIS, Oct. 21 If ... be a sweet experience. Celebrity chef,and author Michael Chiarello, of Food ...
... 21 /Xinhua-PRNewswire/ -- Mindray Medical,International Limited (NYSE: ... medical devices worldwide announced today that it will ... from October,29 to November 1., Mindray will ... core product,segments: patient monitoring & life support products, ...
... SectorWatch.biz announces the,availability of MarketStats for health ... today. MarketStats offers a perspective on the,aforementioned equities ... blogs and opinions., Investors can view MarketStats ... FiSpace.net, a dynamic social networking site for,investors., ...
... consumer wants service, convenience, and quality from their physician, all while saving ... is a service today,s consumer demands. Physicians can now meet this ... ... OH (PRWEB) October 21, 2008 -- Three out of four Americans would ...
... dentistry in Mexico at fraction of the US cost. Andy got ... in one sitting. Overseas Dentistry, including dental implants abroad cost ... ... Burbank, CA (PRWEB) October 21, 2008 -- Andy Gobienko was eating a ...
Cached Medicine News:Health News:Genaera Receives Non-Compliance Notice From NASDAQ 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 2Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 3Health News:Good News for Trick-or-Treaters With Braces: Renowned Chef to the Rescue With Braces-Friendly Treats 4Health News:Mindray Medical to Exhibit New Products at 60th China International Medical Equipment Fair 2Health News:SectorWatch.biz Issues MarketStats on NWCI, ERES, STJ, MDT, BSX, and CSCX 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 2Health News:Physician Dispensing Wins In A Landslide Majority Of Enhancing Patient Experience 3Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 2Health News:Dental Crown in Mexico -- Medical Tourism Corporation Assists US Teen with Huge Savings 3
The cementless acetabular shells form part of the Mallory head range of femoral and acetabular implants....
The cementless BiHAPro cup combines proven concepts with the latest innovations in cementless THR....
Trident Hemispherical Acetabular Shells are a true hemispherical shape designed to achieve press-fit fixation by under-reaming the acetabulum....
The Secur-Fit cups incorporate enhancements derived from years of clinical, radiographic, and implant retrieval observations....
Medicine Products: